The overall goal of this project is to manufacture an oil derived from algae which is enriched in omega-3 polyunsaturated fatty acids. Preliminary data have shown there is a diatom which produces a non-membrane associated triglyceride with a high content of EPA but low contents of other polyunsaturated fatty acids, and is more stable to oxidation. However, this organism is an obligate prototroph. The proposal aims to transform this strain into a heterotroph so that it can be produced by fermentation in large quantities and provide an economical source of an oil enriched in EPA. The strategy proposed is to first determine if this strain transports glucose. If it doesn't the investigators will try to transform it using the glucose transporter gene from another microorganism. If this strategy is unsuccessful, total transformation or mutagenesis and selection will be attempted. In phase 2, the procedure will be optimized using the developed strain to prepare for commercialization of a """"""""designer oil.""""""""

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Small Business Innovation Research Grants (SBIR) - Phase I (R43)
Project #
1R43HL047286-01
Application #
3502121
Study Section
Nutrition Study Section (NTN)
Project Start
1991-09-01
Project End
1992-02-29
Budget Start
1991-09-01
Budget End
1992-02-29
Support Year
1
Fiscal Year
1991
Total Cost
Indirect Cost
Name
Martek Bioscience Corporation
Department
Type
DUNS #
City
Columbia
State
MD
Country
United States
Zip Code
21045